ArticleBMJ open2021

Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen).

Roni Bitterman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.